EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms.
Nanotechnol Sci Appl
; 15: 17-31, 2022.
Article
in En
| MEDLINE
| ID: mdl-35818431
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Nanotechnol Sci Appl
Year:
2022
Document type:
Article
Country of publication:
Nueva Zelanda